Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma

Multiple myeloma (MM) is a plasma cell malignancy that is characterized by diverse clinical presentations. Although biochemical assessment of disease activity is commonly used to monitor treatment response, findings on magnetic resonance imaging and positron emission tomography (PET)/computed tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Charalampous, Charalampos, Goel, Utkarsh, Broski, Stephen M., Dingli, David, Kapoor, Prashant, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Hayman, Suzanne R., Buadi, Francis, Hwa, Lisa, Leung, Nelson, Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis V., Warsame, Rahma, Fonder, Amie, Hobbs, Miriam, Binder, Moritz, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092399/
https://www.ncbi.nlm.nih.gov/pubmed/35235951
http://dx.doi.org/10.1182/bloodadvances.2022007052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092399/
https://www.ncbi.nlm.nih.gov/pubmed/35235951
http://dx.doi.org/10.1182/bloodadvances.2022007052

Ejemplares similares